NYSE (USA) TSX (CANADA)

Directory of Stock Market Company

This site is a directory of Stock Market Company in USA and Canada. Each company page contains a description, stock quote, news and much more. You have also access to the best stock market game on the web.

Search into NYSE and TSX
by quote, company name or key word

facebooktwitterlinkedin
Mail

ALTH - Allos Therapeutics Inc

Allos Therapeutics, Inc. (Allos), incorporated on September 1, 1992, is a biopharmaceutical company engaged in the development and commercialization of anti-cancer therapeutics. The Company is focused on the development and commercialization of FOLOTYN (pralatrexate injection). FOLOTYN is a targeted antifolate inhibitor designed to accumulate preferentially in cancer cells. FOLOTYN targets the inhibition of dihydrofol","NYSE, Nasdaq, S&P, trading, US market, Asian market, Dow Jones, FTSE, DJIA, DAX, stocks, bonds, shares","Connect to the most current information on stocks and bonds on Reuters.com. What you need to know now about NYSE, Dow Jones, S&P, and Nasdaq at Reuters.com"

# ALTHhart

Allos Therapeutics Inc News


Arena Wins FDA Advisory Panel Backing for Obesity Pill
Proactive Investors USA & Canada - May 11, 2012
Below is a look at some of the headlines for companies that made news in the healthcare sector on May 10, 2012. Advisers to government health regulators late Thursday recommended that they approve sales of what would be the first new prescription ...

Colorado stocks: StarTek posts 46% gain
Denver Business Journal - May 10, 2012
Wall Street snapped a six-day streak of declines Thursday, with the Dow Jones Industrial Average adding almost 20 points. The Dow closed at 12855.

Spectrum, Allos Receive Requests From FTC On Planned Tieup; Tender Offer Extended
Wall Street Journal - May 10, 2012
Spectrum Pharmaceuticals Inc.'s (SPPI) tender offer for Allos Therapeutics Inc. (ALTH) has been extended after both companies received requests from regulators for further information on the planned tieup.
Spectrum Pharmaceuticals and Allos Therapeutics Announce Extension of ... - EON: Enhanced Online News (press release)

Spectrum Pharmaceuticals and Allos Therapeutics Announce Extension of ...
MarketWatch (press release) - May 10, 2012
HENDERSON, Nev., May 10, 2012 (BUSINESS WIRE) -- Spectrum Pharmaceuticals, Inc. (nasdaqgs:SPPI) (Spectrum) and Allos Therapeutics, Inc. (nasdaqgs:ALTH) (Allos) today announced that, on May 9, 2012, each had received from the Federal Trade Commission ...

Spectrum Pharmaceuticals Inc And Allos Therapeutics, Inc. Announce Extension Of Previously Announced Tender Offer For Shares Of Allos Therapeutics, Inc.
Reuters Key Development - May 10, 2012

AMAG Pharma Hires Heiden As CEO; Co Downplays Sale Option
Wall Street Journal - May 10, 2012
AMAG Pharmaceuticals Inc. (AMAG) hired William K. Heiden as its new president and chief executive while downplaying the immediate prospect of a sale of the company.

Research Analysts' Ratings Reiterations for May, 7th (ABT, AIV, ALJ, ALTH, AOL ...
Junction Report - May 7, 2012
Abbott Laboratories (NYSE: ABT) had its “neutral” rating re-affirmed by analysts at Zacks. They now have a $66.00 price target on the stock.

Tang Capital's Holdings: Insights Into Successful Investing
Seeking Alpha - May 7, 2012
Examining the regulatory filings of successful hedge funds can often give investors valuable insight into the thinking of top investment managers.

Allos Narrows Loss, Awaits Takeover
Zacks.com - May 7, 2012
Allos Therapeutics (ALTH - Analyst Report) suffered a loss of 11 cents in the first quarter of 2012 as opposed to a loss of 14 cents per share incurred in the year-ago quarter.
Zacks Reiterates Outperform on Allos Therapeutics Incorporated (ALTH) - Junction Report

Top Losers in After-hours Today, May-4
Fyxnews - May 4, 2012
Georgia Gulf Corp. (NYSE:GGC) is currently trading at $31.62 down -7.7% in after-hours on 642270 shares traded. GGC is trading 2.42% above its 50 day moving average and 40.83% above its 200 day moving average.

NYSE Media Coverage Selection of the best articles found in your favorit medias

Next Company >>